EA200501053A1 - Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы - Google Patents

Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы

Info

Publication number
EA200501053A1
EA200501053A1 EA200501053A EA200501053A EA200501053A1 EA 200501053 A1 EA200501053 A1 EA 200501053A1 EA 200501053 A EA200501053 A EA 200501053A EA 200501053 A EA200501053 A EA 200501053A EA 200501053 A1 EA200501053 A1 EA 200501053A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
tryaminobenzene
disorders
treatment
nervous system
Prior art date
Application number
EA200501053A
Other languages
English (en)
Other versions
EA008589B1 (ru
Inventor
Марио Роттлёндер
Андреас Ритзен
Мортен Банг Нергор
Николай Ханжин
Торнее Кристиан Венсель
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200501053(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2003/000906 external-priority patent/WO2004058739A1/en
Publication of EA200501053A1 publication Critical patent/EA200501053A1/ru
Publication of EA008589B1 publication Critical patent/EA008589B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к производным 1,2,4-триаминобензола общей формулы I или их фармацевтически приемлемым солям и к их применению.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200501053A 2002-12-27 2003-12-18 Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы EA008589B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202012 2002-12-27
PCT/DK2003/000906 WO2004058739A1 (en) 2002-12-27 2003-12-18 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Publications (2)

Publication Number Publication Date
EA200501053A1 true EA200501053A1 (ru) 2005-12-29
EA008589B1 EA008589B1 (ru) 2007-06-29

Family

ID=35295526

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501053A EA008589B1 (ru) 2002-12-27 2003-12-18 Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы

Country Status (17)

Country Link
KR (1) KR20050089862A (ru)
CN (1) CN100448867C (ru)
AR (1) AR042656A1 (ru)
BR (1) BR0317748A (ru)
CL (1) CL2003002748A1 (ru)
EA (1) EA008589B1 (ru)
HK (1) HK1088317A1 (ru)
IS (1) IS2649B (ru)
MY (1) MY139844A (ru)
NO (1) NO20053612L (ru)
PE (1) PE20041015A1 (ru)
PL (1) PL377221A1 (ru)
SI (1) SI1578740T1 (ru)
TW (1) TWI325414B (ru)
UA (1) UA79666C2 (ru)
UY (1) UY28151A1 (ru)
ZA (1) ZA200504565B (ru)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (de) * 1992-01-08 1993-07-15 Asta Medica Ag Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
DE19539861A1 (de) * 1995-10-26 1997-04-30 Asta Medica Ag Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
US6117900A (en) * 1999-09-27 2000-09-12 Asta Medica Aktiengesellschaft Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) * 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders

Also Published As

Publication number Publication date
IS7856A (is) 2005-05-23
CN1732162A (zh) 2006-02-08
ZA200504565B (en) 2006-08-30
TW200413280A (en) 2004-08-01
CN100448867C (zh) 2009-01-07
EA008589B1 (ru) 2007-06-29
CL2003002748A1 (es) 2005-04-08
UA79666C2 (en) 2007-07-10
UY28151A1 (es) 2004-07-30
NO20053612D0 (no) 2005-07-25
KR20050089862A (ko) 2005-09-08
HK1088317A1 (en) 2006-11-03
BR0317748A (pt) 2005-11-22
TWI325414B (en) 2010-06-01
PE20041015A1 (es) 2005-01-08
SI1578740T1 (sl) 2007-08-31
MY139844A (en) 2009-11-30
NO20053612L (no) 2005-09-23
IS2649B (is) 2010-08-15
AR042656A1 (es) 2005-06-29
PL377221A1 (pl) 2006-01-23

Similar Documents

Publication Publication Date Title
CY1106645T1 (el) Παραγωγα 1,2,4 τριαμινοβενζολης χρησιμα για τη θεραπευτικη αντιμετωπιση διαταραχων του κεντρικου νευρικου συστηματος
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
EA200300248A1 (ru) Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
EA200301142A1 (ru) Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6
EA200200716A1 (ru) Арилконденсированные азаполициклические соединения
EA200200873A1 (ru) Новые пиперазиновые производные
EA200501009A1 (ru) Замещённые пирролопиразольные производные в качестве ингибиторов киназы
CY1111733T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
DE69718194D1 (de) Amidinophenyl-pyrrolidine, -pyrroline und -isoxazolidine und ihre derivate
CY1108808T1 (el) Ενωσεις μοτιλιδης
MXPA05010000A (es) Derivados de p-diaminobenceno substituidos.
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
EA200500849A1 (ru) Новые соединения лапахона и способы их применения
ATE277072T1 (de) Sapogenin derivate zur behandlung von kognitiven störungen
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
MXPA05009282A (es) Derivados de anilina sustituidos.
EA200701758A1 (ru) Замещённые арильные производные 1,4-пиразина
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200201232A1 (ru) Производные сульфонамида
EA200501299A1 (ru) Замещенные производные анилина
EA200200749A1 (ru) Производные гетероциклического амида
EA200201234A1 (ru) Производные сульфонамида

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU